Global oncology experts gathered in Zurich, Switzerland, on June 27, 2026, for the ETOP IBCSG Partners Foundation ADC Workshop.
The event focused on therapeutic advances in antibody-drug conjugates (ADCs), a targeted cancer treatment that spares healthy tissue.
>>> Ty Gibbs Secures First Career Cup Road Course Pole at Sonoma
Lung Cancer Session Highlights
David Planchard, Head of the Thoracic Cancer Group at Gustave Roussy, emphasized the importance of the workshop.
He described it as a must-attend event for discussing ADCs and sharing advances across different cancers and specialties.
>>> South Korea Scrambles Jets as Russian, Chinese Aircraft Enter ADIZ
A dedicated lung cancer session featured presentations by oncologists Solange Peters and Giannis Mountzios. Their talks generated significant discussion on implementing recent therapeutic updates in thoracic oncology.
>>> Croatia vs Ghana: Decisive World Cup Group Stage Clash
Planchard, a professor at the University Paris Saclay, praised the session on social media. He noted the superb quality of the presentations and discussions.
